Internal Medicine, Medical Oncology · Stanford, CA
NPI
1669413449
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 498-5710
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
253 services
Medicare patients, 2024
67
Average age 74
Drug cost, 2024
$535K
104 prescriptions
Company payments, 2025
$4,659
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haruka Itakura was code 99215 (office e&m - established), 89 times for 34 patients. In total Haruka Itakura billed 253 services in 13 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 89 | 34 | $125.75 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 53 | 31 | $14.70 | $779 |
| 99214 Office E&M - Established | Facility | 20 | 13 | $74.76 | $1,495 |
| 99215 Office E&M - Established | Office | 18 | 12 | $172.49 | $3,105 |
By year: 2022 $22K for 223 services; 2023 $22K for 236 services; 2024 $22K for 253 services.
Medicare prescription drug claims, 2024
In 2024, the drug Haruka Itakura prescribed most often to Medicare patients was Anastrozole, with 20 prescriptions and refills. In total Haruka Itakura wrote 104 Medicare prescriptions that cost $535K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 20 | 57 | Under 11 | $2,003 |
| Exemestane Generic | 17 | 45 | Under 11 | $1,282 |
| Lapatinib Lapatinib Ditosylate | 13 | 13 | Under 11 | $66K |
| Orserdu Elacestrant Hcl | 12 | 12 | Under 11 | $277K |
Brand drugs: 32 claims; generic drugs: 72 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haruka Itakura $4,659 ($4,659 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $4,529.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 3 | $4,529 |
| Caris MPI, Inc. | 1 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.